ARS Pharmaceuticals, Inc. (SPRY)

NASDAQ: SPRY · IEX Real-Time Price · USD

10.54

+0.09 (0.91%)

At close: Jul 19, 2024, 4:00 PM

11.00

+0.46 (4.36%)

Pre-market: Jul 22, 2024, 7:01 AM EDT

ARS Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Revenue	0.01	0.03	1.32	5.51	0	0	Upgrade
Revenue Growth (YoY)	-98.51%	-97.72%	-76.10%	-	-	-	Upgrade
Gross Profit	0.01	0.03	1.32	5.51	0	0	Upgrade
Selling, General & Admin	43.06	47.28	18.46	4.69	8.34	2.56	Upgrade
Research & Development	18.95	20.27	18.38	20.27	24.58	21.51	Upgrade
Operating Expenses	62.01	67.55	36.83	24.96	32.92	24.07	Upgrade
Operating Income	-62	-67.52	-35.52	-19.45	-32.92	-24.07	Upgrade
Interest Expense / Income	0	0	0	0	0.03	-0.1	Upgrade
Other Expense / Income	-12.3	-13.16	-0.83	0.79	-	-	Upgrade
Pretax Income	-49.7	-54.37	-34.68	-20.24	-32.95	-23.97	Upgrade
Net Income	-49.7	-54.37	-34.68	-20.24	-32.95	-23.97	Upgrade
Shares Outstanding (Basic)	96	95	40	29	3	1	Upgrade
Shares Outstanding (Diluted)	96	95	40	29	3	1	Upgrade
Shares Change	2.40%	138.30%	38.39%	893.01%	339.94%	9.45%	Upgrade
EPS (Basic)	-0.52	-0.57	-0.87	-0.70	-11.33	-36.27	Upgrade
EPS (Diluted)	-0.52	-0.57	-0.87	-0.70	-11.33	-36.27	Upgrade
Free Cash Flow	-53.61	-59.44	-40.28	-17.62	-32.11	-18.99	Upgrade
Free Cash Flow Per Share	-0.56	-0.62	-1.01	-0.61	-11.04	-28.74	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	-	-	Upgrade
Operating Margin	-619990.00%	-225066.67%	-2698.78%	-353.32%	-	-	Upgrade
Profit Margin	-496960.00%	-181216.67%	-2635.41%	-367.65%	-	-	Upgrade
Free Cash Flow Margin	-536120.00%	-198136.67%	-3060.56%	-319.94%	-	-	Upgrade
EBITDA	-49.63	-54.29	-34.65	-20.03	-31.21	-22.52	Upgrade
EBITDA Margin	-496320.00%	-180973.33%	-2632.83%	-363.78%	-	-	Upgrade
Depreciation & Amortization	0.06	0.07	0.03	0.21	1.71	1.55	Upgrade
EBIT	-49.7	-54.37	-34.68	-20.24	-32.92	-24.07	Upgrade
EBIT Margin	-496960.00%	-181216.67%	-2635.41%	-367.65%	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).